SCHEMBL24405804

SCHEMBL24405804

CN(C)c1ccc(C#N)c(-n2c(=O)n(C)c3ccccc32)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.40
▸ AR P10275 4/20 0.37
▸ GABRA1 P14867 1/20 0.37
▸ GABRG2 P18507 1/20 0.37
▸ GABRB3 P28472 1/20 0.37
▸ GABRA3 P34903 1/20 0.37
▸ GABRA2 P47869 1/20 0.37
▸ ALDH1A1 P00352 6/20 0.36
▸ KDM4E B2RXH2 5/20 0.36
▸ POLB P06746 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ BCL6 P41182 1/20 0.36
▸ HPGD P15428 3/20 0.35
▸ HSD17B10 Q99714 3/20 0.35
▸ MAPT P10636 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ P2RX4 Q99571 1/20 0.34
▸ PGR P06401 1/20 0.34
▸ GLA P06280 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24405997 0.81 MAPT (0.39) CYP1A2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24405919 0.81 CYP1A2 (0.47) CYP1A2ARALDH1A1KDM4EPOLB
SCHEMBL24405778 0.80 RXFP1 (0.41) CYP1A2ALDH1A1KDM4EPOLBRXFP1
SCHEMBL13376862 0.64 PGR (0.64) CYP1A2ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL24405665 0.63 TP53 (0.53) ALDH1A1KDM4EMAPTNPSR1PGR
SCHEMBL29798837 0.62 CYP1A2 (0.55) CYP1A2ALDH1A1KDM4EHSD17B10PGR
SCHEMBL474339 0.62 CYP1A2 (0.55) CYP1A2ALDH1A1KDM4EHSD17B10PGR
SCHEMBL4300398 0.62 TSHR (0.45) ALDH1A1KDM4EHSD17B10MAPTGAA
SCHEMBL6362809 0.62 PGR (0.68) CYP1A2ALDH1A1KDM4EPGRSMN1; SMN2
SCHEMBL4301269 0.62 PSMB5 (0.42) ARGABRA1GABRG2GABRB3GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774739-B1 FUSED CYCLIC UREA DERIVATIVES AS CRHR2 ANTAGONIST RAQUALIA PHARMA INC (JP) 2022-05-11 — — EP disclosed
Send feedback